Mission
The mission of ISFTD is to promote world-wide clinical practice, clinical research, innovative treatments, and
basic research on FTD. This mission will be pursued through publications, webinars, courses, yearly
conferences, town-hall membership meetings, interactions with pharmaceutical companies, advocacy, and
administrative infrastructure. We further aim to encourage interdisciplinary interactions, facilitate
communications among members, catalyze international projects, and pro-actively reach out to
investigators and clinicians at early career stages and in less developed countries.